Mar 13 2024University of Pennsylvania School of Medicine Targeting two brain tumor-associated proteins-; rather than one-; with CAR T cell therapy shows promise as a strategy for reducing solid tumor growth in patients with recurrent glioblastoma , an aggressive form of brain cancer, according to early results from the first six patients treated in an ongoing Phase I clinical trial led by researchers from the Perelman School of Medicine at the University of Pennsylvania and Penn Medicine's...
GBM is the most common-;and most aggressive-;type of cancerous brain tumor in adults. Individuals with GBM usually expect to live 12-18 months following their diagnosis. Despite decades of research, there is no known cure for GBM, and approved treatments-;such as surgery, radiation, and chemotherapy-;have limited effect in prolonging an individual's life expectancy. However, even after aggressive treatment, GBM returns in most patients, which is known as recurrent GBM.
In this trial, researchers used a technology developed in the lab of Donald M. O'Rourke, MD, the John Templeton, Jr., MD Professor in Neurosurgery and director of the Glioblastoma Translational Center of Excellence at the Abramson Cancer Center, and scientific advisor to the trial.
Source: Healthcare Press (healthcarepress.net)
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Man killed in apparent car-to-car shooting on Mass. highway, police sayA man was killed and another person wounded in an apparent car-to-car shooting on Interstate 391 in Chicopee, Massachusetts, on Tuesday night, state police…
Source: NECN - 🏆 20. / 71 Read more »
'Dual-target' cell therapy appears to shrink brain tumors, research findsTargeting two brain tumor-associated proteins—rather than one—with CAR T cell therapy shows promise as a strategy for reducing solid tumor growth in patients with recurrent glioblastoma (GBM), an aggressive form of brain cancer, according to early results from the first six patients treated in an ongoing Phase I clinical trial led by...
Source: medical_xpress - 🏆 101. / 51 Read more »
New bone tool could offer speedy screening for new treatments targeting pain in osteoarthritisResearchers at St George's, University of London have developed a simple tool to measure irregularities in the cartilage and bone tissue of people with osteoarthritis, which aims to speed-up screening for tissue changes and testing new treatments for those with chronic pain.
Source: medical_xpress - 🏆 101. / 51 Read more »
Targeting a non-encoding stretch of RNA may shrink pediatric brain tumors in miceTargeting a non-encoding stretch of RNA may help shrink tumors caused by an aggressive type of brain cancer in children, according to new research in mice reported March 8 in Cell Reports by Johns Hopkins Kimmel Cancer Center investigators.
Source: NewsMedical - 🏆 19. / 71 Read more »
Novel therapy harnesses stem cell-derived exosomes for diabetic wound healingResearchers unveiled a novel therapy for diabetic wound healing. This research highlights the use of exosomal miR-4645-5p from hypoxic bone marrow mesenchymal stem cells (BMSCs) to significantly enhance wound healing by promoting keratinocyte autophagy.
Source: NewsMedical - 🏆 19. / 71 Read more »
Culture Chat: Margaret Atwood, John Grisham and friends write a novelIn an experiment whose proceeds will go to the Authors Guild of America, 36 authors including Margaret Atwood, John Grisham, Dave Eggers, and Celeste Ng, wrote a collaborative novel
Source: FT - 🏆 113. / 51 Read more »